Kimberly-Clark Corporation
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Kimberly-Clark Corporation (KMB). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | Q1 2025 | Q2 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|
| NA | $2.67B 65.8% | $2.73B 65.6% | $2.65B 63.7% | $2.70B 64.4% |
| IPC | $1.39B 34.2% | $1.43B 34.4% | $1.51B 36.3% | $1.49B 35.6% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
| Segment | Q1 2025 | Q2 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|
| NA | $678.0M 25.4% | $655.0M 24.0% | $623.0M 23.5% | $725.0M 26.9% |
| IPC | $201.0M 14.5% | $182.0M 12.7% | $245.0M 16.2% | $186.0M 12.5% |
Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.
Revenue by product line
| Segment | Q1 2025 | Q2 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|
| Baby and Child Care | $1.64B 40.4% | $1.77B 42.5% | $1.70B 40.7% | $1.75B 41.8% |
| Family Care | $1.03B 25.3% | $1.00B 23.9% | $1.04B 25.0% | $1.02B 24.2% |
| Adult Care | $476.0M 11.7% | $492.0M 11.8% | $483.0M 11.6% | $493.0M 11.8% |
| Professional | $446.0M 11.0% | $465.0M 11.2% | $460.0M 11.0% | $476.0M 11.4% |
| Feminine Care | $443.0M 10.9% | $412.0M 9.9% | $451.0M 10.8% | $423.0M 10.1% |
| All other | $25.0M 0.6% | $29.0M 0.7% | $33.0M 0.8% | $30.0M 0.7% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.